title: Bilateral vertebral giant cell arteritis--favourable outcome in two cases.
authors.forename: R
authors.initials: R
authors.lastname: Sutter
authors.forename: S
authors.initials: S
authors.lastname: Renaud
authors.forename: L
authors.initials: L
authors.lastname: Bonati
authors.forename: P
authors.initials: P
authors.lastname: Lyrer
authors.forename: M
authors.initials: M
authors.lastname: Tolnay
authors.forename: S
authors.initials: S
authors.lastname: Wetzel
authors.forename: S
authors.initials: S
authors.lastname: Rüegg
authors.forename: S
authors.initials: S
authors.lastname: Engelter
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D001933:Brain Stem / Q000098:blood supply / Q000473:pathology / Q000503:physiopathology; D002531:Cerebellum / Q000098:blood supply / Q000473:pathology / Q000503:physiopathology; D004305:Dose-Response Relationship, Drug; D005260:Female; D013700:Giant Cell Arteritis / Q000188:drug therapy / Q000503:physiopathology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D008279:Magnetic Resonance Imaging; D008297:Male; D008775:Methylprednisolone / Q000008:administration & dosage; D016896:Treatment Outcome; D014463:Ultrasonography; D014711:Vertebral Artery / Q000000981:diagnostic imaging / Q000473:pathology / Q000503:physiopathology*; D014715:Vertebrobasilar Insufficiency / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology*
chemical_list: D007166:Immunosuppressive Agents; D008775:Methylprednisolone